EUVIMEDEUVIMED entdecken
Crossref

Dissecting the role of SPRY4-IT1 and TUG1 in modulating miR-425/TGF-β/ Smad signaling in mediating renal fibrosis and inflammation in lupus nephritis: Novel biomarkers and therapeutic targets

Mai A Abd-Elmawla, Mahmoud Zidan, Yumn A Elsabagh, Nourhan Elfar, Abdullah F Radwan

International Immunopharmacology · 2025-09 · 162 · 115132

DOI: 10.1016/j.intimp.2025.115132 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025-09. Verfasst von Mai A Abd-Elmawla und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Electronic address: mei.abdelmawla@pharma.cu.edu.eg. Hauptthemen laut MEDLINE: MicroRNAs, Lupus Nephritis, RNA, Long Noncoding, Kidney. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lupus nephritis (LN), the severe complication of systemic lupus erythematosus (SLE), is driven by inflammation and fibrosis, often leading to chronic kidney diseases. The current study aimed to elucidate the roles of long non-coding RNAs (lncRNAs) SPRY4-IT1 and TUG1, and miR-425 in modulating the TGF-β/Smad signaling pathway and to assess their potential as biomarkers and therapeutic targets. A case-control study was conducted involving 100 participants, including LN patients (n = 35), SLE patients without LN (n = 35), and healthy controls (n = 30). Serum expression levels of SPRY4-IT1, TUG1, miR-425 and Smads were measured using qRT-PCR, while TGF-β, fibronectin,TNF-α and PIIINP were analyzed via ELISA. The results showed a significant upregulation of SPRY4-IT1 and TUG1 and a downregulation of miR-425 in LN patients compared to controls (p < 0.01). These ncRNAs demonstrated strong correlations with TGF-β, Smad2/3, and other fibrotic markers, while inversely correlating with miR-425. ROC curve analysis identified SPRY4-IT1 as the most robust diagnostic marker (AUC = 0.85, sensitivity = 82 %, specificity = 70 %). Pathway analyses confirmed their involvement in inflammatory and fibrotic processes. These findings suggest that SPRY4-IT1 and TUG1 contribute to LN pathogenesis through the miR-425/TGF-β/Smad axis, underscoring their potential as novel diagnostic and therapeutic targets. Further research in larger cohorts is warranted to validate these findings and explore clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsLupus NephritisRNA, Long NoncodingKidneyHumansFemaleAdultFibrosisMaleSignal TransductionBiomarkersCase-Control StudiesTransforming Growth Factor betaInflammationMiddle AgedSmad ProteinsYoung Adult

Stichwörter der Autor:innen

Diagnostic biomarkersInflammationLupusNephritisSPRY4-IT1SmadTGF-βTUG1miR-425

Substanzen

MicroRNAsRNA, Long NoncodingBiomarkersTransforming Growth Factor betaTUG1 long noncoding RNA, humanMIRN425 microRNA, humanlong noncoding RNA SPRY4-IT1, humanSmad Proteins

Autor:innen und Institutionen

  • Biochemistry Department, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt. Electronic address: mei.abdelmawla@pharma.cu.edu.eg.
  • Internal Medicine Department (Nephrology Unit), Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Internal Medicine Department (Rheumatology and Clinical Immunology Unit), Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Biochemistry Department, School of Health and Social work, University of Hertfordshire Hosted by Global Academic Foundation, New Administrative Capital, 11578 Cairo, Egypt; Egyptian Drug Authority (EDA), Ministry of Hea…
  • Collage of Pharmacy, University of Kut, Wasit, 52001, Iraq; Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Cairo 11829, Egypt.

Zitieren

APA

Abd-Elmawla, M. A., Zidan, M., Elsabagh, Y. A., Elfar, N., & Radwan, A. F. (2025). Dissecting the role of SPRY4-IT1 and TUG1 in modulating miR-425/TGF-β/ Smad signaling in mediating renal fibrosis and inflammation in lupus nephritis: Novel biomarkers and therapeutic targets. International Immunopharmacology, 162, 115132. https://doi.org/10.1016/j.intimp.2025.115132

Vancouver

Abd-Elmawla MA, Zidan M, Elsabagh YA, Elfar N, Radwan AF. Dissecting the role of SPRY4-IT1 and TUG1 in modulating miR-425/TGF-β/ Smad signaling in mediating renal fibrosis and inflammation in lupus nephritis: Novel biomarkers and therapeutic targets. International Immunopharmacology. 2025;162:115132. doi:10.1016/j.intimp.2025.115132

BibTeX
@article{AbdElmawla2025,
  author = {Abd-Elmawla, Mai A and Zidan, Mahmoud and Elsabagh, Yumn A and Elfar, Nourhan and Radwan, Abdullah F},
  title = {Dissecting the role of SPRY4-IT1 and TUG1 in modulating miR-425/TGF-β/ Smad signaling in mediating renal fibrosis and inflammation in lupus nephritis: Novel biomarkers and therapeutic targets},
  journal = {International Immunopharmacology},
  year = {2025},
  volume = {162},
  pages = {115132},
  doi = {10.1016/j.intimp.2025.115132}
}
Kostenlos starten →